Lv1
40 积分 2024-03-22 加入
Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessment
1天前
已完结
Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae
10天前
已完结
Diagnostic BRAFV600E blood predicts treatment failure and neurodegeneration and redefines paradigms of pediatric LCH
2个月前
已关闭
BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis
3个月前
已完结
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads
4个月前
已完结
BRAF V600E-positive mononuclear cells in blood at diagnosis portend treatment failure and neurodegeneration in pediatric LCH
4个月前
已关闭
皖公网安备34019202002308
